Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma?

Onkologie

Volumn 26, Issue 3, 2003, Pages 261-267

  Haas, Inge ^a   Ganzer, U ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Esthesioneuroblastoma; Immunohistochemistry; Neuroectodermal tumors, differential diagnosis

Indexed keywords

ANTINEOPLASTIC AGENT; CHROMOGRANIN; CYTOKERATIN; NERVE PROTEIN; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100; SYNAPTOPHYSIN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENDOSCOPY; ESTHESIONEUROBLASTOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MULTIMODALITY CANCER THERAPY; NEUROECTODERM TUMOR; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUS CARCINOMA; PARANASAL SINUS TUMOR; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STAINING; TREATMENT OUTCOME; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION;

ADULT; AGED; BIOPSY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; ENDOSCOPY; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROECTODERMAL TUMORS; NOSE; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PARANASAL SINUSES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0038301997     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071622     Document Type: Article

References (48)

1. Schmidt MB: Über seltene Spaltbildungen im Bereiche des mittleren Stirnfortsatzes. Virchow Arch Path Anat 1900;162:340.
2. Sussenguth L: Über Nasengliome. Virchow Arch Path Anat 1909;195.
3. Berger L, Luc R: Esthesioneuroepitheliome olfactif. Bull Assoc Franc Cancer 1924;13:410-421.
4. Berger L, Coutard H: L'esthesioneurocytome olfactif. Bull Assoc Franc Cancer 1926;15:404-414.
5. Portmann NM, Bonnard ET: Sur un cas de tumeur nerveuse des fosses nasales (esthesioneuroblastome). Acta Otolaryngol 1928;13:52-57.
6. Schall LA, Lineback M: Primary intranasal neuroblastoma: Report of 3 cases. Ann Otol Rhinol Laryngol 1951;60:221-229.
7. Seaman WB: Olfactory esthesioneuroepitheliomas. Radiology 1951;57:541-546.
8. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC: Esthesioneuroblastoma. Cancer 1979;44:1087-1094.
9. Miyamoto RC, Gleich LL, Biddinger PW, Gluckman JL: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: Impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 2000;110:1262-1265.
10. Dulguerov P, Calcaterra T: Esthesioneuroblastoma: The UCLA experience 1970-1990. Laryngoscope 1992;102:843-849.
11. Irish J, Dasgupta R, Freeman J, Gullane P, Gentili F, Brown D, Neligan P, O'Sullivan B: Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997;26:1-7.
12. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH: Esthesioneuroblastoma: The Johns Hopkins experience. Head Neck 2000;22:550-558.
13. Chao KS, Kaplan C, Simpson R, Haughey B, Spector GJ, Sessions DG, Arquette M: Esthesioneuroblastoma: The impact of treatment modality. Head Neck 2001;23:749-757.
14. Dulguerov P, Allal AS, Calcaterra TC: Esthesioneuroblastoma: A meta-analysis and review. Lancet Oncol 2001;2:683-690.
15. Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ: Esthesioneuroblastoma and cervical lymph node metastases: Clinical and therapeutic implications. Acta Otolaryngol 2002;122:215-221.
16. Pape H, Wurm R, Schmitt G: Pathogenese und Klinik der ästhesioneuroblastome. Tumordiagn Ther 1990;11:237-242.
17. Silva EG, Butler JJ, Mackay B, Goepfert H: Neuroblastomas and neuroendocrine carcinomas of the nasal cavity. Cancer 1982;50:2388-2405.
18. Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC: Esthesioneuroblastoma. Long-term outcome and patterns of failure - the University of Virginia experience. Cancer 1994;73:2556-2562.
19. Levine PA, Gallagher R, Cantrell RW: Esthesioneuroblastoma: Reflections of a 21-year experience. Laryngoscope 1999;109:1539-1543.
20. Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE: Esthesioneuroblastoma - what is the optimal treatment? Acta Oncol 2000;39:231-235.
21. Simon JH, Zhen W, McCulloch TM, Hoffman HAT, Paulino AC, Mayr NA, Buatti JM: Esthesioneuroblastoma: The University of Iowa experience 1978-1998. Laryngoscope 2001;111:488-493.
22. Hyams VJ, Batsakis JG, Morales AR: Olfactory neuroblastoma in special tumors of the head and neck. Chicago, ASCPPress, 1982, pp 24-29.
23. Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976;37:1571-1576.
24. Biller HF, Lawson W, Sachdev VP, Som P: Esthesioneuroblastoma: Surgical treatment without radiation. Laryngoscope 1990;100:1199-1201.
25. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM: Esthesioneuroblastoma: Prognosis and management. Neurosurgery 1993;32:706-715.
26. Delank KW: Das Olfaktoriusneuroblastom - Tumorentität oder klinischer Formenkreis? Laryngorhinootologie 1990;69:426-432.
27. Zumegen C, Michel O: Problematik der Klassifikation und Prognose des Ästhesioneuroblastoms anhand von sieben therapierten Fällen. Laryngorhinootologie 2000;79:736-742.
28. Jahnke K, Arnold W: Die Bedeutung der Elektronenmikroskopie für Klinik und Forschung in der Hals-Nasen-Ohrenheilkunde. Anat Anz 1987;163:63-78.
29. Min KW: Usefulness of electronmicroscopy in the diagnosis of 'small' round cell tumors of the sinonasal region. Ultrastruct Pathol 1995;19:347-363.
30. Wick MR: Immunohistology of neuroendocrine and neuroectodermal tumors. Sem Diagn Pathol 2000;17:194-203.
31. Mills SE: Neuroectodermal Neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002;15:264-278.
32. Finkelstein SD, Hirose T, VandenBerg SR: Olfactory neuroblastoma; in Kleihues P, Cavenee WK (eds): Pathology & Genetics. Tumours of the Nervous System. Oxford, University Press, 2000, pp 150-152.
33. Lund VJ, Milroy C: Olfactory neuroblastoma: Clinical and pathological aspects. Rhinol 1993;31:1-6.
34. Devoe K, Weidner N: Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol 2000;17:216-224.
35. Perez-Ordonez B, Caruana, SM, Huvos AG, Shah JP: Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Human Pathol 1998;29:826-832.
36. Moll R, Franke WW, Schiller Dr, Geiger B,Krepler R: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
37. Richardson MS: Pathology of skull base tumors. Otolaryngol Clin North Am 2001;34:1025-1042.
38. Mezzelani A, Tornielli S, Minoletti F, Pierotti MA, Sozzi G, Pilotti S: Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. Br J Cancer 1999;81:586-591.
39. Devaney K, Wenig BM, Abbondanzo SL: Olfactory neuroblastoma and other round cell lesions of the sinonasal region. Mod Pathol 1996;9:658-663.
40. Righi PD, Francis F, Aron BS: Sinonasal undifferentiated carcinoma: A 10-year experience. Am J Otolaryngol 1996;17:167-171.
41. Nelson RS, Perlman EJ, Askin FB: Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Human Pathol 1995;26:639-641.
42. Saint-André JP, Valo I, Guyetant S: Immunohistochimie des tumeurs neuro-endocrines. Ann Pathol 2000;20(suppl):129-131.
43. Knöbber D, Lobeck H, Schnoy N: Ästhesioneuroblastom: Diagnosesicherung durch Immunhistologie und Elektronenmikroskopie. Laryngorhinootologie 1993;391-397.
44. Okabe H, Okubo T, Adachi H, Ishikawa T, Iwai M, Miyahira Y, Ochi Y: Problems of the immunohistochemical differential diagnosis of neuroendocrine carcinoma and neuroblastomas. Rinsho Byori 1997;45:850-855.
45. Stosiek P, Kasper M, Moll R: Changes in cytokeratin expression accompany squamous metaplasia of human respiratory epithelium. Virchows Arch A Pathol Anat Histopathol 1992;421:133-141.
46. Hirose TH, Scheithauer BW, Lopes MBS, Gerber HA, Altermatt HJ, Harner SG, VandenBerg SR: Olfactory Neuroblastoma. An immunohistochemical, ultrastructural and flow cytometric study. Cancer 1995;76:4-19.
47. Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M: Vimentin is preferentially expressed in human breast carcinoma with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 1990;136:219-227.
48. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Torri J, Donahue S, Lippman ME: Association of increased membrane invasiveness with absence of estrogen receptor and expression of vimentin in breast cancer cell lines. J Cell Physiol 1992;150:534-544.